LIFETECH SCI announced its interim results, with profit attributable to owners of the company amounting to HKD 55.074 million, a year-on-year decrease of 73.21%
I'm PortAI, I can summarize articles.
LIFETECH SCI announced its mid-term results for 2025, with revenue of approximately 677 million yuan, an increase of 3.7% year-on-year. Gross profit was approximately 498 million yuan, a decrease of 3.4% year-on-year. Profit attributable to the company's owners was 55.074 million yuan, a decrease of 73.21% year-on-year; earnings per share were 1.3 cents. The increase in revenue was mainly due to the sales of coated stents and left atrial appendage occluders. The gross profit margin decreased by 5.3 percentage points year-on-year to 73.6%, and the decline in net profit was mainly due to changes in non-recurring items
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments